HUP0401141A3 - Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them - Google Patents
Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0401141A3 HUP0401141A3 HU0401141A HUP0401141A HUP0401141A3 HU P0401141 A3 HUP0401141 A3 HU P0401141A3 HU 0401141 A HU0401141 A HU 0401141A HU P0401141 A HUP0401141 A HU P0401141A HU P0401141 A3 HUP0401141 A3 HU P0401141A3
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- crystalline forms
- fluvastatin sodium
- Prior art date
Links
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 title 1
- 229960000868 fluvastatin sodium Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/04—Sodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01810756 | 2001-08-03 | ||
| PCT/EP2002/008276 WO2003013512A2 (en) | 2001-08-03 | 2002-07-25 | Crystalline forms of fluvastatin sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401141A2 HUP0401141A2 (hu) | 2004-09-28 |
| HUP0401141A3 true HUP0401141A3 (en) | 2011-07-28 |
Family
ID=8184071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401141A HUP0401141A3 (en) | 2001-08-03 | 2002-07-25 | Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6696479B2 (hu) |
| EP (1) | EP1429757B8 (hu) |
| JP (2) | JP4681808B2 (hu) |
| KR (1) | KR100975782B1 (hu) |
| CN (2) | CN102516150A (hu) |
| AR (1) | AR036205A1 (hu) |
| AT (1) | ATE391502T1 (hu) |
| AU (1) | AU2002333271B2 (hu) |
| CA (1) | CA2454072A1 (hu) |
| DE (1) | DE60226044T2 (hu) |
| ES (1) | ES2304140T3 (hu) |
| HU (1) | HUP0401141A3 (hu) |
| IL (2) | IL159861A0 (hu) |
| PL (1) | PL366905A1 (hu) |
| RU (1) | RU2334738C2 (hu) |
| WO (1) | WO2003013512A2 (hu) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7087631B2 (en) * | 2002-07-18 | 2006-08-08 | Inotek Pharmaceuticals Corporation | Aryltetrazole compounds, and compositions thereof |
| EP1525189A1 (en) * | 2002-07-26 | 2005-04-27 | Ciba Specialty Chemicals Holding Inc. | Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| WO2004096765A2 (en) * | 2003-05-01 | 2004-11-11 | Morepen Laboratories Ltd. | A novel crystalline polymorph of fluvastatin sodium and a process for preparing it |
| US7368581B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of fluvastatin sodium crystal from XIV |
| US7368468B2 (en) * | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| EP1726583A3 (en) * | 2003-06-18 | 2007-05-09 | Teva Pharmaceutical Industries Ltd | Fluvastatin sodium crystal form LXXIX, processes for preparing it, compositions containing it and methods of using it. |
| WO2005037424A1 (en) * | 2003-10-06 | 2005-04-28 | Solvias Ag | Process for the parallel detection of crystalline forms of molecular solids |
| US7432380B2 (en) | 2003-10-16 | 2008-10-07 | Ciba Specialty Chemicals Corp. | Crystalline form of Fluvastatin sodium |
| US20070179166A1 (en) * | 2003-12-24 | 2007-08-02 | Valerie Niddam-Hildesheim | Process for preparation of statins with high syn to anti ratio |
| US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| WO2005080332A1 (en) * | 2004-01-14 | 2005-09-01 | Cadila Healthcare Limited | Novel form of fluvastatin sodium |
| US20070173536A1 (en) * | 2004-02-06 | 2007-07-26 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of zolmitriptan |
| US7241800B2 (en) | 2004-03-17 | 2007-07-10 | Mai De Ltd. | Anhydrous amorphous form of fluvastatin sodium |
| WO2006021967A1 (en) * | 2004-08-26 | 2006-03-02 | Biocon Limited | Process for the preparation of fluvastatin sodium form a. |
| WO2006030304A2 (en) * | 2004-09-17 | 2006-03-23 | Ranbaxy Laboratories Limited | Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof |
| US7795451B2 (en) * | 2005-02-11 | 2010-09-14 | Jubilant Organosys Limited | Polymorphic forms of fluvastatin sodium and process for preparing the same |
| WO2006109147A1 (en) * | 2005-04-12 | 2006-10-19 | Glenmark Pharmaceuticals Limited | Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same |
| WO2007039784A2 (en) * | 2005-10-06 | 2007-04-12 | Wockhardt Limited | A novel crystalline polymorph of fluvastatin sodium and process for preparing it |
| US20090082572A1 (en) * | 2005-11-14 | 2009-03-26 | Hetero Drugs Limited | Process for amorphous esomeprazole |
| JP2007246522A (ja) * | 2006-02-27 | 2007-09-27 | Teva Pharmaceutical Industries Ltd | フルバスタチンナトリウムの新規形及びその調製方法 |
| US20110015247A1 (en) * | 2008-04-04 | 2011-01-20 | Shodhana Laboratories Limited | Novel crystalline form of carvedilol dihydrogen phosphate and related processes |
| CN101684121B (zh) * | 2008-09-22 | 2013-04-03 | 重庆医药工业研究院有限责任公司 | 培美曲塞二酸的新晶型及其制备方法 |
| JP6115288B2 (ja) * | 2012-04-27 | 2017-04-19 | 株式会社島津製作所 | 質量分析におけるピーク検出方法及びそのシステム |
| TW201806928A (zh) * | 2016-07-01 | 2018-03-01 | 第一三共股份有限公司 | 胺基羧酸之酸加成鹽的結晶及其製造方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| AU570021B2 (en) * | 1982-11-22 | 1988-03-03 | Novartis Ag | Analogs of mevalolactone |
| PH23486A (en) * | 1982-11-22 | 1989-08-16 | Sanzoz Inc | Indole analogs of mevalonolactone,pharmaceutical compositions containing the same and method of use thereof |
| HRP960313B1 (en) | 1995-07-17 | 2002-08-31 | Warner Lambert Co | Form iii crystalline (r- (r*, r*)-2- (4-fluorophenyl) -beta-delta-hydroxy-5-(1-methylethyl) -3-phenyl-4- ((phenylamino) carbonyl -1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| US6124340A (en) * | 1996-06-24 | 2000-09-26 | Astra Aktiebolag | Polymorphic compounds |
| JP2004513112A (ja) * | 2000-10-31 | 2004-04-30 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | フルバスタチンナトリウムの結晶形 |
-
2002
- 2002-07-25 IL IL15986102A patent/IL159861A0/xx active IP Right Grant
- 2002-07-25 CN CN2011103995817A patent/CN102516150A/zh active Pending
- 2002-07-25 ES ES02794517T patent/ES2304140T3/es not_active Expired - Lifetime
- 2002-07-25 EP EP02794517A patent/EP1429757B8/en not_active Expired - Lifetime
- 2002-07-25 DE DE60226044T patent/DE60226044T2/de not_active Expired - Lifetime
- 2002-07-25 KR KR1020047001615A patent/KR100975782B1/ko not_active IP Right Cessation
- 2002-07-25 RU RU2004106528/04A patent/RU2334738C2/ru not_active IP Right Cessation
- 2002-07-25 AT AT02794517T patent/ATE391502T1/de not_active IP Right Cessation
- 2002-07-25 WO PCT/EP2002/008276 patent/WO2003013512A2/en active IP Right Grant
- 2002-07-25 HU HU0401141A patent/HUP0401141A3/hu unknown
- 2002-07-25 AU AU2002333271A patent/AU2002333271B2/en not_active Ceased
- 2002-07-25 PL PL02366905A patent/PL366905A1/xx not_active Application Discontinuation
- 2002-07-25 JP JP2003518521A patent/JP4681808B2/ja not_active Expired - Fee Related
- 2002-07-25 CA CA002454072A patent/CA2454072A1/en not_active Abandoned
- 2002-07-25 CN CN028151321A patent/CN1536999B/zh not_active Expired - Fee Related
- 2002-07-30 US US10/208,687 patent/US6696479B2/en not_active Expired - Lifetime
- 2002-08-01 AR ARP020102927A patent/AR036205A1/es unknown
-
2004
- 2004-01-14 IL IL159861A patent/IL159861A/en not_active IP Right Cessation
-
2010
- 2010-07-23 JP JP2010165635A patent/JP2010265308A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE391502T1 (de) | 2008-04-15 |
| US20030032666A1 (en) | 2003-02-13 |
| IL159861A0 (en) | 2004-06-20 |
| ES2304140T3 (es) | 2008-09-16 |
| RU2004106528A (ru) | 2005-07-27 |
| WO2003013512A2 (en) | 2003-02-20 |
| CN1536999B (zh) | 2012-08-08 |
| WO2003013512A3 (en) | 2003-11-20 |
| DE60226044T2 (de) | 2009-05-14 |
| EP1429757B8 (en) | 2008-07-16 |
| AU2002333271B2 (en) | 2007-08-09 |
| KR100975782B1 (ko) | 2010-08-17 |
| JP4681808B2 (ja) | 2011-05-11 |
| HUP0401141A2 (hu) | 2004-09-28 |
| CN102516150A (zh) | 2012-06-27 |
| DE60226044D1 (de) | 2008-05-21 |
| IL159861A (en) | 2009-02-11 |
| US6696479B2 (en) | 2004-02-24 |
| EP1429757A2 (en) | 2004-06-23 |
| PL366905A1 (en) | 2005-02-07 |
| RU2334738C2 (ru) | 2008-09-27 |
| AR036205A1 (es) | 2004-08-18 |
| JP2005501838A (ja) | 2005-01-20 |
| EP1429757B1 (en) | 2008-04-09 |
| JP2010265308A (ja) | 2010-11-25 |
| CN1536999A (zh) | 2004-10-13 |
| KR20040022226A (ko) | 2004-03-11 |
| CA2454072A1 (en) | 2003-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401141A3 (en) | Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them | |
| HUP0302519A3 (en) | Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them | |
| HU228253B1 (en) | Substituted cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0400998A3 (en) | Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them | |
| HUP0402161A3 (en) | Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102814A3 (en) | New gamma crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it | |
| HU0102813D0 (en) | New betha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it | |
| HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
| HUP0200580A3 (en) | Polymorphic crystalline forms of celecoxib, process their preparation and pharmaceutical compositions containing them | |
| HUP0304042A2 (hu) | Cefemszármazékok és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására | |
| HUP0204005A3 (en) | Novel forms of pravastatin sodium, process for their preparation and pharmaceutical compositions containing them | |
| HUP0300389A3 (en) | Crystalline form ii of cabergoline, process for its preparation and pharmaceutical compositions containing it | |
| HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303105A3 (en) | Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU2003231920A8 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| SI1245565T1 (en) | Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0200913A3 (en) | Isoindoindololone derivatives process for their preparation and pharmaceutical compositions containing them | |
| HUP0400207A3 (en) | Substituted 4-aminocyclohexanol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0200993A3 (en) | Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0202293A3 (en) | Novel n-benzylpiperazine compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201135A2 (en) | Substituted benzolactam compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |